NCT04392154 · Interventional trial
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Overall registry status Completed
Phase 3
Conditions Atopic Dermatitis
Delaware Valley sites
- Paddington Testing Company Inc · Philadelphia, PA · Philadelphia County
- Psoriasis Treatment Center of Central New Jersey · East Windsor, NJ · Mercer County
- The Pennsylvania Centre for Dermatology, LLC · Exton, PA · Chester County
- University of Pennsylvania Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory